CentralReach the leading provider of autism and IDD care software today announced the appointment of Rick Russo as the companys Chief Financial Officer CFO

CentralReach Appoints SaaS Finance Veteran to Leadership Team

CentralReach, the leading provider of autism and IDD care software, recently announced the appointment of Rick Russo as the company’s Chief Financial Officer (CFO). With over 30 years of experience, including multiple leading software companies, Russo brings a strong track record of building and scaling finance and accounting teams. Russo will lead financial operations and be a strategic thought partner to the leadership team as CentralReach continues to meet the unprecedented demand for its market-leading Autism and IDD Care Platform. 

“I’m thrilled to welcome Rick to the team,” said Chris Sullens, CEO of CentralReach. “In the past four years, CentralReach has experienced rapid and profitable growth with no signs of slowing down. As we look to the future, I have no doubt that Rick’s extensive financial, operational, and strategic experience will help us scale even more effectively and efficiently. I look forward to partnering with Rick as we take CentralReach through the next phase of our growth journey.” 

Reporting directly to Sullens, Russo joins CentralReach’s recent key leadership hires, Chief Revenue Officer Drew Hamilton, Chief Operating Officer Clark Convery, and Chief Technology Officer Sean Banerjee, to help Sullens accelerate improvements to the customer experience, scale the company’s products and technology and drive continued growth at scale. 

“I am honored to join CentralReach as CFO,” said Russo. “What CentralReach is doing really stands out. Not only does the company have an incredible growth story, but they are doing it in a way that has kept its mission at the center of it all. I’m eager to apply my experience to help CentralReach scale in a way that continues to support the autism and IDD community and those that serve them.” 

Prior to joining CentralReach, Russo most recently served as the Chief Financial Officer at ETQ, a leading enterprise SaaS quality management software company, where he drove strategic initiatives that transformed the company in terms of scale and financial profile. Prior to joining ETQ, he served as SVP and Chief Accounting Officer and VP of Finance at Epicor Software, a leading enterprise ERP software company. Previously, he held various financial positions, including Senior Director of Corporate FP&A at Solectron Corporation, a global electronics manufacturing company. Rick holds a BS in accounting from the State University of New York, Brockport.  

About CentralReach 

CentralReach is the leading provider of autism and IDD care software, providing the only complete, end-to-end software and services platform that helps children and adults diagnosed with autism spectrum disorder (ASD) and related intellectual and developmental disabilities (IDD) – and those who serve them – unlock potential, achieve better outcomes, and live more independent lives. With its roots in Applied Behavior Analysis, the company is revolutionizing how the lifelong journey of autism and IDD care is enabled at home, school, and work with powerful and intuitive solutions purpose-built for each care setting.  

Trusted by more than 130,000 professionals globally, CentralReach is committed to ongoing product advancement, market-leading industry expertise, world-class client satisfaction, and support of the autism and IDD community to propel autism and IDD care into a new era of excellence. For more information, please visit LinkedIn, Facebook, and Twitter. 

The Editorial Team at Healthcare Business Today is made up of skilled healthcare writers and experts, led by our managing editor, Daniel Casciato, who has over 25 years of experience in healthcare writing. Since 1998, we have produced compelling and informative content for numerous publications, establishing ourselves as a trusted resource for health and wellness information. We offer readers access to fresh health, medicine, science, and technology developments and the latest in patient news, emphasizing how these developments affect our lives.